There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Intralesional epidermal growth factor (EGF) has been available as a medication in
Turkey since 2012. We present the results of our experience using intralesional EGF
in Turkey for patients with diabetic foot wounds.